Global 5a-Reductase Inhibitors Market Growth 2025-2031

The global 5α-Reductase Inhibitors market size is predicted to grow from US$ 895 million in 2025 to US$ 1293 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.

5α-Reductase inhibitors are a class of medications that block the action of the enzyme 5α-reductase, which converts testosterone into dihydrotestosterone (DHT), a more potent androgen. By reducing DHT levels, these inhibitors can help treat conditions such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness). Common examples include finasteride and dutasteride.

United States market for 5α-Reductase Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for 5α-Reductase Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for 5α-Reductase Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key 5α-Reductase Inhibitors players cover Organon, GSK, Waylis Therapeutics, Dr. Reddy's Laboratories, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “5α-Reductase Inhibitors Industry Forecast” looks at past sales and reviews total world 5α-Reductase Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected 5α-Reductase Inhibitors sales for 2025 through 2031. With 5α-Reductase Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 5α-Reductase Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global 5α-Reductase Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 5α-Reductase Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 5α-Reductase Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 5α-Reductase Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 5α-Reductase Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of 5α-Reductase Inhibitors market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Dutasteride
Finasteride

Segmentation by Application:
Male Pattern Baldness
Benign Prostatic Hyperplasia (BPH)
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Organon
GSK
Waylis Therapeutics
Dr. Reddy's Laboratories
Teva
Aurobindo Pharma
Zydus
Hetero
Accord Healthcare
Sun Pharma
Alkem
Amneal Pharmaceuticals
Strides Pharma
Chartwell
Humanwell Pharmaceutical
Grand Pharmaceutical
CR Double-Crane
Zhejiang Conba Pharmaceutical
Topfond Pharmaceutical
Zhejiang Xianju Pharmaceutical
Shanghai Shyndec Pharmaceutical
Humanwell Puracap
Sichuan Gowell Pharmaceutical
Chengdu Suncadia Medicine
Qilu Pharmaceutical
Jiangsu Wangao Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global 5α-Reductase Inhibitors market?

What factors are driving 5α-Reductase Inhibitors market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 5α-Reductase Inhibitors market opportunities vary by end market size?

How does 5α-Reductase Inhibitors break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.